Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease

Circulation

Volumn 104, Issue 4, 2001, Pages 387-392

  Schartl, Michael ^a,c   Bocksch, Wolfgang ^a   Koschyk, Dietmar H ^d   Voelker, Wolfram ^e   Karsch, Karl R ^f   Kreuzer, Jörg ^g   Hausmann, Dirk ^h   Beckmann, Stephan ^b   Gross, Michael ^c  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b VIVANTES KLINIKUM AM URBAN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Arteriosclerosis; Coronary disease; Lipids; Plaque; Ultrasonics

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035943069     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc2901.093188     Document Type: Article

References (34)

1. Coronary plaque disruption
2. Molecular bases of the acute coronary syndromes
3. Stability and instability: Two faces of coronary atherosclerosis
4. Acute coronary syndromes: Biology
5. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease
6. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
7. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
9. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
10. The Monitored Atherosclerosis Regression Study (MARS): Coronary angiographic changes with lovastatin therapy
11. Effect of simvastatin on coronary atheroma: The Multicenter Anti-Atheroma Study (MAAS)
12. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels
13. Retardation and arrest of progression or regression of coronary artery disease: A review
14. Lipid lowering and plaque regression
15. Volumetric intracoronary ultrasound: A new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis?
16. Histopathologic validation of intracoronary ultrasound imaging
17. Intracoronary ultrasound-defined plaque composition: Computer-aided plaque characterization and correlation with histologic samples obtained during directional coronary atherectomy
18. Accuracy of measurements in quantitative coronary angiography (QCA)
19. In vitro validation of automated plaque echogenicity quantification of intracoronary ultrasound images
20. Morphometric analysis in three-dimensional intracoronary ultrasound: An in vitro and in vivo study performed with a novel system for the contour detection of lumen and plaque
21. Reproducibility of serial intravascular ultrasound measurements in patients with angiographically silent coronary artery disease after heart transplantation
22. In vitro analysis of coronary atheromatous lesions by intravascular ultrasound
23. Determinants and correlates of target lesion calcium in coronary artery disease: A clinical, angiographic and intravascular ultrasound study
24. Reduction of serum-cholesterol levels alters lesional composition of atherosclerotic plaques: Effects of pravastatin sodium on atherosclerosis in mature WHHL rabbits
25. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
26. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma
27. The evolving role of statins in the management of atherosclerosis
28. The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Trial: Effects of intensive atorvastatin treatment on early recurrent events after acute coronary syndrome
29. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin
30. Compensatory enlargement of human atherosclerotic coronary arteries
31. Effect of monotherapy with HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis is assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention trial
32. Coronary plaque disruption
33. Ultrasonic imaging of microscopic structures in living organs
34. Rationale for a postintervention continuum of care: Insights from intravascular ultrasound